2021 Q1 Form 10-Q Financial Statement
#000156459021025131 Filed on May 07, 2021
Income Statement
Concept | 2021 Q1 | 2020 Q1 |
---|
Balance Sheet
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $638.8M | $450.5M |
YoY Change | 41.8% | 206.67% |
Cash & Equivalents | $638.8M | $450.5M |
Short-Term Investments | ||
Other Short-Term Assets | $2.251M | $2.142M |
YoY Change | 5.09% | 77.46% |
Inventory | ||
Prepaid Expenses | $24.53M | $16.15M |
Receivables | $90.10M | $54.10M |
Other Receivables | $900.0K | $600.0K |
Total Short-Term Assets | $837.1M | $561.6M |
YoY Change | 49.06% | 141.88% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $36.35M | $34.19M |
YoY Change | 6.32% | 1.08% |
Goodwill | $520.1M | $101.0M |
YoY Change | 414.79% | 28.15% |
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $83.50M | $34.20M |
YoY Change | 144.15% | 59.81% |
Total Long-Term Assets | $764.8M | $244.3M |
YoY Change | 213.06% | 52.21% |
TOTAL ASSETS | ||
Total Short-Term Assets | $837.1M | $561.6M |
Total Long-Term Assets | $764.8M | $244.3M |
Total Assets | $1.602B | $805.9M |
YoY Change | 98.77% | 105.23% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $18.40M | $15.30M |
YoY Change | 20.26% | 60.44% |
Accrued Expenses | $69.15M | $45.19M |
YoY Change | 53.03% | 2.25% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $389.5M | $267.8M |
YoY Change | 45.44% | 31.66% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $129.8M | $61.40M |
YoY Change | 111.4% | 3246.05% |
Total Long-Term Liabilities | $129.8M | $61.40M |
YoY Change | 111.4% | 3246.05% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $389.5M | $267.8M |
Total Long-Term Liabilities | $129.8M | $61.40M |
Total Liabilities | $520.4M | $329.6M |
YoY Change | 57.89% | 47.33% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $1.081B | $476.3M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $1.602B | $805.9M |
YoY Change | 98.77% | 105.23% |
Cashflow Statement
Concept | 2021 Q1 | 2020 Q1 |
---|
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
|
P10Y | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y10M20D | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y8M19D | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y1M9D | |
CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0082 | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0125 | |
CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
3983000 | |
CY2020Q4 | avlr |
Receivables From Customers Allowance For Doubtful Accounts
ReceivablesFromCustomersAllowanceForDoubtfulAccounts
|
593000 | |
CY2021Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
85760000 | |
CY2021Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
85760000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
85058000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
85058000 | |
CY2021Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
600000000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
600000000 | |
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
9000 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1640867000 | |
CY2020Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1339000 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-559377000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1080160000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1602333000 | |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
153601000 | |
CY2020Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
111443000 | |
CY2021Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
44671000 | |
CY2020Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
34254000 | |
CY2021Q1 | us-gaap |
Gross Profit
GrossProfit
|
108930000 | |
CY2020Q1 | us-gaap |
Gross Profit
GrossProfit
|
77189000 | |
CY2021Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
39156000 | |
CY2020Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
25847000 | |
CY2021Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
64304000 | |
CY2020Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
49634000 | |
CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
30851000 | |
CY2020Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
21388000 | |
CY2021Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
134311000 | |
CY2020Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
96869000 | |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-25381000 | |
CY2020Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-19680000 | |
CY2021Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
24000 | |
CY2020Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1442000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-29988000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15283000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-390000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
625000 | |
CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-30378000 | |
CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-14658000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-29988000 | |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
18777000 | |
CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
9731000 | |
CY2021Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7071000 | |
CY2020Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4091000 | |
CY2021Q1 | us-gaap |
Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
|
345000 | |
CY2020Q1 | us-gaap |
Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
|
0 | |
CY2021Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
2028000 | |
CY2020Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
62000 | |
CY2021Q1 | avlr |
Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
|
2175000 | |
CY2020Q1 | avlr |
Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
|
1956000 | |
CY2021Q1 | avlr |
Non Cash Change In Earnout Liability
NonCashChangeInEarnoutLiability
|
1350000 | |
CY2020Q1 | avlr |
Non Cash Change In Earnout Liability
NonCashChangeInEarnoutLiability
|
-2509000 | |
CY2021Q1 | avlr |
Provision For Bad Debts Expense Recovery
ProvisionForBadDebtsExpenseRecovery
|
582000 | |
CY2020Q1 | avlr |
Provision For Bad Debts Expense Recovery
ProvisionForBadDebtsExpenseRecovery
|
631000 | |
CY2021Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
389000 | |
CY2020Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
10000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
14695000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
2750000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
9186000 | |
CY2021Q1 | avlr |
Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
|
-2360000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
85436000 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.35 | |
CY2020Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
4745000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
85436000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | |
CY2020Q1 | avlr |
Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
|
-2250000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-541000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
384000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-1895000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
3659000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-15634000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-18568000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
15841000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
4128000 | |
CY2021Q1 | avlr |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-2810000 | |
CY2020Q1 | avlr |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-2230000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-28247000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-24471000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1366000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
883000 | |
CY2021Q1 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
2311000 | |
CY2020Q1 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
717000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5844000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1600000 | |
CY2021Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
5529000 | |
CY2020Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
7928000 | |
CY2021Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
7088000 | |
CY2020Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
5716000 | |
CY2021Q1 | avlr |
Payments For Acquisition Related Post Closing
PaymentsForAcquisitionRelatedPostClosing
|
1971000 | |
CY2020Q1 | avlr |
Payments For Acquisition Related Post Closing
PaymentsForAcquisitionRelatedPostClosing
|
0 | |
CY2021Q1 | us-gaap |
Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
|
0 | |
CY2020Q1 | us-gaap |
Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
|
3760000 | |
CY2021Q1 | us-gaap |
Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
|
690000 | |
CY2020Q1 | us-gaap |
Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
|
65000 | |
CY2021Q1 | avlr |
Net Increase Decrease In Customer Fund Obligations
NetIncreaseDecreaseInCustomerFundObligations
|
3598000 | |
CY2020Q1 | avlr |
Net Increase Decrease In Customer Fund Obligations
NetIncreaseDecreaseInCustomerFundObligations
|
3915000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
13554000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
13734000 | |
CY2021Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
6000 | |
CY2020Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-365000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-20531000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-12702000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
761844000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
491333000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
741313000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
478631000 | |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
638794000 | |
CY2020Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
450535000 | |
CY2021Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
68886000 | |
CY2020Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
0 | |
CY2021Q1 | us-gaap |
Restricted Cash Equivalents
RestrictedCashEquivalents
|
33633000 | |
CY2020Q1 | us-gaap |
Restricted Cash Equivalents
RestrictedCashEquivalents
|
28096000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
741313000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
478631000 | |
CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | |
CY2020Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | |
CY2020Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
3108000 | |
CY2021Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
3493000 | |
CY2020Q1 | avlr |
Stock Based Compensation Costs Capitalized To Internally Developed Software
StockBasedCompensationCostsCapitalizedToInternallyDevelopedSoftware
|
36000 | |
CY2021Q1 | avlr |
Stock Based Compensation Costs Capitalized To Internally Developed Software
StockBasedCompensationCostsCapitalizedToInternallyDevelopedSoftware
|
225000 | |
CY2021Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
153000 | |
CY2020Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
320000 | |
CY2021Q1 | us-gaap |
Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
|
0 | |
CY2020Q1 | us-gaap |
Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
|
3750000 | |
CY2021Q1 | avlr |
Accrued Purchase Price Related To Acquisitions
AccruedPurchasePriceRelatedToAcquisitions
|
178000 | |
CY2020Q1 | avlr |
Accrued Purchase Price Related To Acquisitions
AccruedPurchasePriceRelatedToAcquisitions
|
0 | |
CY2021Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
1263000 | |
CY2020Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
743000 | |
CY2021Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.</span></p></td> <td valign="top"> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="font-style:italic;">Nature of Operations </span></p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.54%;text-indent:-4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:2.13%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Avalara, Inc. (the “Company”) provides software solutions that help businesses of all types and sizes comply with transaction tax requirements worldwide. The Company offers a broad and growing suite of compliance solutions for transaction taxes, such as sales and use tax, value-added tax (“VAT”), fuel excise tax, beverage alcohol, cross-border taxes (including tariffs and duties), lodging tax, and communications tax. These solutions enable customers to automate the process of determining taxability, identifying applicable tax rates, determining and collecting taxes, preparing and filing returns, remitting taxes, maintaining tax records, and managing compliance documents. The Company, a Washington corporation, was originally incorporated in 1999 and is headquartered in Seattle, Washington.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:2.27%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:2.13%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has wholly owned subsidiaries outside of the U.S. in Brazil, Canada, Europe, and India, which conduct sales and operations and provide business development, software development, and support services.</p> | |
CY2021Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:2.13%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.67%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts have been reclassified to conform to current period presentation.</p> | |
CY2021Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
CY2021Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:2.13%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:2.13%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates and judgments related to revenue are described below in the Revenue Recognition Accounting Policy. Significant estimates impacting expenses include: expected credit losses associated with the allowance for doubtful accounts; the measurement of fair values of stock-based compensation award grants; the expected payout level of performance share unit grants; the expected earnout obligations in connection with acquisitions; the expected term of the customer relationship for capitalized contract cost amortization; the valuation and useful lives of acquired intangible assets; the valuation of the fair value of reporting units for analyzing goodwill; and the capitalization and useful life of capitalized software development costs. Actual results could materially differ from those estimates.</p> | |
CY2021Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
CY2020 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
CY2021Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
|
1400000 | |
CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
|
-2500000 | |
CY2021Q1 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
CY2020Q1 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
CY2021Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
13539000 | |
CY2021Q1 | avlr |
Revenue Recognition Contractual Renewal Period
RevenueRecognitionContractualRenewalPeriod
|
P1Y | |
CY2021Q1 | us-gaap |
Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
|
greater than 50% | |
CY2021Q1 | avlr |
Percentage Of Likelihood Of Realization Of Tax Position Upon Ultimate Settlement Minimum
PercentageOfLikelihoodOfRealizationOfTaxPositionUponUltimateSettlementMinimum
|
0.50 | |
CY2021Q1 | us-gaap |
Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
|
30 days | |
CY2021Q1 | avlr |
Concessions And Cancellations Period Allowed For Standard Subscription Contract Prior To Adoption
ConcessionsAndCancellationsPeriodAllowedForStandardSubscriptionContractPriorToAdoption
|
P60D | |
CY2021Q1 | us-gaap |
Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
|
P6Y | |
CY2021Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
67891000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
63772000 | |
CY2021Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
31544000 | |
CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
29059000 | |
CY2021Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
36347000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
34713000 | |
CY2021Q1 | us-gaap |
Depreciation
Depreciation
|
2600000 | |
CY2020Q1 | us-gaap |
Depreciation
Depreciation
|
2300000 | |
CY2021Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
24528000 | |
CY2020Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
13968000 | |
CY2021Q1 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
2801000 | |
CY2020Q4 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
2557000 | |
CY2021Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
2251000 | |
CY2020Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
3573000 | |
CY2021Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
29580000 | |
CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
20098000 | |
CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
7903000 | |
CY2021Q1 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
4919000 | |
CY2020Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
111443000 | |
CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
10413000 | |
CY2021Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
69151000 | |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
84532000 | |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
153601000 | |
CY2020Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
4338000 | |
CY2021Q1 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
9577000 | |
CY2020Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
29518000 | |
CY2021Q1 | us-gaap |
Self Insurance Reserve Current
SelfInsuranceReserveCurrent
|
1633000 | |
CY2020Q4 | us-gaap |
Self Insurance Reserve Current
SelfInsuranceReserveCurrent
|
1563000 | |
CY2021Q1 | avlr |
Accrued Employee Stock Purchase Plan Contributions Current
AccruedEmployeeStockPurchasePlanContributionsCurrent
|
3617000 | |
CY2020Q4 | avlr |
Accrued Employee Stock Purchase Plan Contributions Current
AccruedEmployeeStockPurchasePlanContributionsCurrent
|
5927000 | |
CY2021Q1 | us-gaap |
Accrued Sales Commission Current
AccruedSalesCommissionCurrent
|
3189000 | |
CY2020Q4 | us-gaap |
Accrued Sales Commission Current
AccruedSalesCommissionCurrent
|
5563000 | |
CY2021Q1 | avlr |
Accrued Partner Commissions Current
AccruedPartnerCommissionsCurrent
|
9010000 | |
CY2020Q4 | avlr |
Accrued Partner Commissions Current
AccruedPartnerCommissionsCurrent
|
9173000 | |
CY2021Q1 | avlr |
Contract Liabilities Current
ContractLiabilitiesCurrent
|
12466000 | |
CY2020Q4 | avlr |
Contract Liabilities Current
ContractLiabilitiesCurrent
|
10134000 | |
CY2021Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
11201000 | |
CY2020Q4 | avlr |
Contract Liabilities Current
ContractLiabilitiesCurrent
|
10134000 | |
CY2019Q4 | avlr |
Contract Liabilities Current
ContractLiabilitiesCurrent
|
5197000 | |
CY2021Q1 | avlr |
Contract With Customer Liabilities Transferred To Deferred Revenue
ContractWithCustomerLiabilitiesTransferredToDeferredRevenue
|
3866000 | |
CY2020Q1 | avlr |
Contract With Customer Liabilities Transferred To Deferred Revenue
ContractWithCustomerLiabilitiesTransferredToDeferredRevenue
|
2538000 | |
CY2021Q1 | avlr |
Contract With Customer Liabilities Additions
ContractWithCustomerLiabilitiesAdditions
|
6198000 | |
CY2020Q1 | avlr |
Contract With Customer Liabilities Additions
ContractWithCustomerLiabilitiesAdditions
|
3671000 | |
CY2021Q1 | avlr |
Contract Liabilities Current
ContractLiabilitiesCurrent
|
12466000 | |
CY2020Q1 | avlr |
Contract Liabilities Current
ContractLiabilitiesCurrent
|
6330000 | |
CY2021Q1 | us-gaap |
Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
|
P6Y | |
CY2021Q1 | us-gaap |
Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
|
0 | |
CY2020Q1 | us-gaap |
Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
|
0 | |
CY2021Q1 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
0 | |
CY2020Q1 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
0 | |
CY2021Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
49600000 | |
CY2021Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
49000000.0 | |
CY2021Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P12M | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
124370000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
49691000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
74679000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
131987000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
45474000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
86513000 | |
CY2021Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
4400000 | |
CY2020Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1800000 | |
CY2020Q4 | us-gaap |
Goodwill
Goodwill
|
513234000 | |
CY2021Q1 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-431000 | |
CY2021Q1 | us-gaap |
Goodwill
Goodwill
|
520120000 | |
CY2018Q4 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
CY2021Q1 | us-gaap |
Number Of Reporting Units
NumberOfReportingUnits
|
3 | |
CY2021Q1 | us-gaap |
Lease Cost
LeaseCost
|
3900000 | |
CY2020Q1 | us-gaap |
Lease Cost
LeaseCost
|
3800000 | |
CY2021Q1 | us-gaap |
Sublease Income
SubleaseIncome
|
400000 | |
CY2020Q1 | us-gaap |
Sublease Income
SubleaseIncome
|
400000 | |
CY2021Q1 | us-gaap |
Lessee Operating Lease Lease Not Yet Commenced Description
LesseeOperatingLeaseLeaseNotYetCommencedDescription
|
No leases commenced in the three months ended March 31, 2021 | |
CY2021Q1 | avlr |
Number Of Classes Of Stock
NumberOfClassesOfStock
|
2 | |
CY2021Q1 | us-gaap |
Capital Units Authorized
CapitalUnitsAuthorized
|
620000000 | |
CY2021Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
600000000 | |
CY2021Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | |
CY2021Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1080160000 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
5529000 | |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
19047000 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
7088000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-390000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-29988000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
463722000 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
7928000 | |
CY2020Q1 | us-gaap |
Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
|
3750000 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
|
87000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
625000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15283000 | |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
476294000 | |
CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
19047000 | |
CY2020Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
9749000 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3537014 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
28.17 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
483577000 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
296226 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
18.67 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
6079 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
15.19 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3234709 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
29.07 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
337587000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2021107 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
20.97 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
227301000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
3234709 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2021107 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
41900000 | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
36800000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | |
CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
28.99 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
306533 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
1213602 | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.43 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-29988000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15283000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
77904000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
77904000 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.20 | |
CY2021Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5736000 | |
CY2020Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
7227000 |